{"id":"W4390261692","doi":"10.1016/j.jns.2023.121719","title":"Phase 3B study evaluating superiority of daily dosing vs approved on/off oral edaravone dosing over 48 weeks in patients with amyotrophic lateral sclerosis (MT-1186-A02)","year":2023,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Dosing; Amyotrophic lateral sclerosis; Edaravone; Medicine; Pharmacology; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001566958,0.002209582,0.004447946,0.0005550137,0.0005029586,0.001311417,0.001419362,0.002102437,0.008835839],"category_scores_gemma":[0.001280247,0.0009286617,0.002706774,0.0005246581,0.001592723,0.001414873,0.0004091571,0.004685897,0.001814376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009888422,"about_ca_system_score_gemma":0.001504414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001501514,"about_ca_topic_score_gemma":0.002576569,"domain_scores_codex":[0.9994535,0.0002190226,0.00002547683,0.0001308071,0.00003709192,0.0001341791],"domain_scores_gemma":[0.9990114,0.0002213228,0.0001465548,0.0001156939,0.00007708299,0.0004278502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9657877,0.01392839,0.0003568891,0.0001713816,0.0004618424,0.0000313198,0.00003734203,0.0003338486,0.006825176,0.00006906992,0.0005909794,0.01140616],"study_design_scores_gemma":[0.7866914,0.2089307,0.002135155,0.00001583258,0.0002770038,0.00003845815,0.00002492202,0.0003532883,0.0007638403,0.0001138732,0.0006329971,0.00002243218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919096,0.001566821,0.0005421634,0.0004687667,0.0003935867,0.001457621,0.002075779,0.0001381281,0.001447585],"genre_scores_gemma":[0.9853137,0.001396063,0.002009233,0.001030979,0.0004072357,0.003100082,0.002638434,0.00006588927,0.004038383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008835839,"threshold_uncertainty_score":0.0295589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1008721483637259,"score_gpt":0.3675271246293192,"score_spread":0.2666549762655933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}